SEC Form 4 · accession 0001209191-17-059300
ALDER BIOPHARMACEUTICALS INC · ALDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clay B Siegall
Director
Period of report
Nov 1, 2017
Accepted (ET)
Nov 3, 2017 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 1, 2017 | M | 9,090 | $1.265 | A | 13,534 | D | |
| Common Stock | Nov 1, 2017 | M | 9,090 | $1.65 | A | 22,624 | D | |
| Common Stock | Nov 1, 2017 | M | 9,090 | $0.99 | A | 31,714 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.265 | Nov 1, 2017 | M | 9,090 | D | — | Nov 13, 2017 | Common Stock | 9,090 | 0 | D |
| Stock Option (Right to Buy)F2 | $1.65 | Nov 1, 2017 | M | 9,090 | D | — | Jul 22, 2018 | Common Stock | 9,090 | 0 | D |
| Stock Option (Right to Buy)F3 | $0.99 | Nov 1, 2017 | M | 9,090 | D | — | Jul 22, 2019 | Common Stock | 9,090 | 0 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of April 30, 2007 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter, for so long as the recipient of the option provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
- F2The shares subject to this option shall vest and become exercisable at a rate of 1/48th of the total number of shares underlying the options each monthly anniversary of March 24, 2008 (the "Vesting Commencement Date"), for so long as the recipient of the option provides continuous service to the Issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
- F3The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of January 1, 2009 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter, for so long as the recipient of the option provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.